
Auricular Transcutaneous Vagus Nerve Stimulation (tVNS) Reduces Anxiety Symptoms: A Longitudinal Randomised Controlled Study
Anxiety disorders affect a significant portion of the population, leading to a growing interest in new treatment approaches. In a study on the Roga tVNS device, researchers found that daily use of auricular transcutaneous vagus nerve stimulation (tVNS) over four weeks significantly reduced anxiety in participants with moderate to severe anxiety. The active treatment group experienced a 47% decrease in GAD-7 scores and a 14% decrease in STAI-S scores, demonstrating that tVNS is a promising and effective non-invasive treatment for long-term stress relief.
Source: Controlled study using Roga devices, funded by MITACS Accelerate grant in Canada. Independently evaluated and approved by the University of Waterloo Human Research Ethics Board (HREB). Published in The Society for Neuroscience and The Brain & Behavior Journal.
Read Study
















